Will the Phase 2 trial "Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer" reach primary completion on or before Jul 15, 2027?

Resolves Yes if ClinicalTrials.gov record NCT03516708 (Washington University School of Medicine) shows an actual primary completion date on or before Jul 15, 2027. Registered date at generation: Jul 15, 2027.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Jul 15, 2027, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.